Alphagan (Brimonidine Tartrate) - Summary

ALPHAGAN SUMMARY

ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.15% is a relatively selective alpha-2 adrenergic agonist for ophthalmic use. The chemical name of brimonidine tartrate is 5-bromo-6- (2-imidazolidinylideneamino) quinoxaline L-tartrate. It is an off-white to pale yellow powder.

ALPHAGAN® P is indicated for the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

ALPHAGAN NEWS HIGHLIGHTS

Published Studies Related to Alphagan (Brimonidine)

Meta-analysis of randomized controlled trials comparing timolol with brimonidine in the treatment of glaucoma. [2008.04]

Effect of brimonidine tartrate 0.15% on scotopic pupil: controlled trial. [2007.10]

Effect of Brimonidine Tartrate 0.15% on Scotopic Pupil-Controlled Trial. [2007.09.27]

Effect of prophylactic brimonidine instillation on bleeding during strabismus surgery in adults. [2007.09]

Effects of topical clonidine versus brimonidine on choroidal blood flow and intraocular pressure during squatting. [2007.09]

more>>

Clinical Trials Related to Alphagan (Brimonidine)

Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension [Completed]

Comparison of Brimonidine Purite, Dorzolamide, and Brinzolamide as Adjunctive Therapy to Prostaglandin Analogs [Completed]

Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan [Completed]

Systemic Bioavailability Study Of Col-118 Administered Topically as a 0.18 % Facial Gel And Brimonidine Ophthalmic Solution 0.2% [Recruiting]

Safety and Efficacy of Brimonidine Intravitreal Implant in Patients With Geographic Atrophy Due to Age-Related Macular Degeneration (AMD) [Not yet recruiting]

more>>